Unique ID issued by UMIN | UMIN000018751 |
---|---|
Receipt number | R000020691 |
Scientific Title | Acute phase intra-stent tissue reduction effect of prasugrel compared with clopidogrel in patient with acute coronary syndrome |
Date of disclosure of the study information | 2015/08/21 |
Last modified on | 2015/08/21 11:02:58 |
Acute phase intra-stent tissue reduction effect of prasugrel compared with clopidogrel in patient with acute coronary syndrome
Acute effect of parsugrel in ACS
Acute phase intra-stent tissue reduction effect of prasugrel compared with clopidogrel in patient with acute coronary syndrome
Acute effect of parsugrel in ACS
Japan |
Acute coronary syndrome
Cardiology |
Others
NO
The aim of this study is to observe acute response of tissue inside the stent after primary PCI for ACS and to compare the effect of novel P2Y12 inhibitor, prasugrel, with clopidogrel.
Efficacy
Exploratory
Others
Not applicable
The primary end point of the study was IST score reduction between the 2 treatment groups.
The secondary end points was the difference in each maximal smooth and irregular IST area reduction between the 2 treatment groups.
Observational
20 | years-old | <= |
100 | years-old | >= |
Male and Female
1)The patient with ACS undergoing primary PCI to curprit lesion with stent implantation.
2)The patient scheduled to be performed secondary OCT after 3days to 1month of primary PCI.
1. Patients who cannot give informed consent.
2. Absolute contraindications or allergy that cannot be pre-medicated to iodinated
contrast or to any of the study medications including both prasgrel and clopidgrel.
3. Contraindications to angiography.
4. If it is known, pregnant or nursing mothers.
5. If it is known, a creatinine clearance <30 mL/min.
6. Previous enrolment in this study.
7. Randomisation or planned use of other investigational drugs or devices in this trial.
8. the opinion of the investigator would result in suboptimal imaging or excessive risk
of complication from placement of an OCT catheter.
9. insufficient OCT image quality
10. stent thrombosis was developed before secondary OCT
11. cardiac arrest
12. PCI performed on the next day after PCI due to unstable hemodynamic status or chest pain
13. Curprit lesion located in (left main trunk or in )the ostial coronary artery or in a previous stent implantation(stent occulusion or stent restenosis) or in a saphenous vein graft ,in arterial bypass.
14. Stroke was developed after PCI
15. uncontrollable heart failure
16. active bleeding
17. active infection
100
1st name | |
Middle name | |
Last name | Toshiro Shinke |
Kobe University Graduate School of Medicine
Division of Cardiology
7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo
078-382-5111
shinke@med.kobe-u.ac.jp
1st name | |
Middle name | |
Last name | Yoshiro Tsukiyama |
Kobe University Graduate School of Medicine
Division of Cardiology
7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo
078-382-5111
yoshiro.tsukiyama0920@gmail.com
Kobe University Graduate School of Medicine
Kobe University Graduate School of Medicine
Self funding
Osaka Saiseikai Nakatsu Hospital
NO
大阪府済生会中津病院(大阪府)
2015 | Year | 08 | Month | 21 | Day |
Unpublished
Open public recruiting
2012 | Year | 06 | Month | 20 | Day |
2015 | Year | 09 | Month | 19 | Day |
2018 | Year | 03 | Month | 31 | Day |
provisional observational study
2015 | Year | 08 | Month | 21 | Day |
2015 | Year | 08 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020691
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |